Immunogenicity Study of the Influenza Vaccine in Adults.
Phase of Trial: Phase II
Latest Information Update: 10 Jan 2014
At a glance
- Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors Sanofi; sanofi pasteur
- 16 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Mar 2009 Planned end date 1 May 2008 added as reported by ClinicalTrials.gov.
- 02 Dec 2008 Results were published in Vaccine.